Core technologies include microscale pumping, microfluidic system design and microfabrication with systems for nanoscale liquid chromatography, HPLC, and microscale pumps
Eksigent Technologies has relocated its corporate headquarters to the Creekside Business Park in Dublin, California.
The new 4000m2 facility, double the company's original space, will accommodate research and development, operations, manufacturing and shipping, as well as sales and marketing and customer service.
The new headquarters space has been customised to meet Eksigent's unique needs and includes a dedicated customer demonstration centre and state-of-the-art research labs for the company's HPLC, medical device and advanced technology product development.
Jeff Jensen, president of Eksigent, commented: "Our company has experienced rapid growth over the past few years, with the successful introductions of our HPLC and drug delivery product lines.
"We're pleased to provide our seventy employees with this new home, which is conveniently located in the heart of the Bay Area.
"As we continue to grow, our new facilities will help us better meet the needs of our current and future customers".
Eksigent Technologies is a pioneer in microfluidic systems that automate and accelerate proteomics, drug discovery, medical devices and other life science applications.
Eksigent's core technologies include microscale pumping, microfluidic system design and microfabrication.
The company offers systems for nanoscale liquid chromatography, high-performance liquid chromatography, and microscale pumps.
